PART 01: Executive summary • Highlights PART 02: Scope of the report • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Companion diagnostics: Promising business model • Reimbursement scenario PART 06: Perspective of LDTs in US • Requirement of regulatory framework • Post implementation scenario PART 07: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 08: Market segmentation by application • Global molecular diagnostics market by infectious disease testing • Global molecular diagnostics market by oncological testing • Global molecular diagnostics market by blood testing • Global molecular diagnostics market by genetic testing • Global molecular diagnostics market by tissue typing PART 09: Geographical segmentation • Molecular diagnostics market in Americas • Molecular diagnostics market in EMEA • Molecular diagnostics market in APAC PART 10: Market drivers • Key to cost-effective diagnosis of cancer • Development of molecular POCT • Increase in investments in genomics and proteomics research PART 11: Impact of drivers PART 12: Market challenges • Reimbursement issues • Threat of low-cost products • Issues with quality control and cold chain management • Ethical issues associated with DTC genetic testing PART 13: Impact of drivers and challenges PART 14: Market trends • Growth of theranostics • Development of NGS technology and DNA arrays • Increase in partnerships • Development of personalized medicine PART 15: Vendor landscape • Abbott Diagnostics • Hologic • Qiagen • Roche Diagnostics • Siemens Healthcare • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Examples of approved companion diagnostics Exhibit 03: Companion diagnostics coverage in the US Exhibit 04: Global molecular diagnostics market 2015-2020 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Segmentation of global molecular diagnostics market by application 2015 Exhibit 07: Global molecular diagnostics market by infectious disease testing 2015-2020 ($ billions) Exhibit 08: Global molecular diagnostic market by oncological testing 2015-2020 ($ billions) Exhibit 09: Global molecular diagnostics market by blood testing 2015-2020 ($ billions) Exhibit 10: Global molecular diagnostics market by genetic testing 2015-2020 ($ billions) Exhibit 11: Global molecular diagnostics market by tissue typing 2015-2020 ($ millions) Exhibit 12: Segmentation of global molecular diagnostics market by geography 2015 Exhibit 13: Molecular diagnostics market in Americas 2015-2020 ($ billions) Exhibit 14: Molecular diagnostics market in EMEA 2015-2020 ($ billions) Exhibit 15: Molecular diagnostics market in APAC 2015-2020 ($ billions) Exhibit 16: Impact of drivers Exhibit 17: Impact of drivers and challenges Exhibit 18: Global molecular diagnostics market by vendors 2014 and 2015 Exhibit 19: Key molecular diagnostic product launches by Roche and Qiagen 2015 Exhibit 20: Key takeaways: Abbott Diagnostics Exhibit 21: Key takeaways: Hologic Exhibit 22: Key takeaways: Qiagen Exhibit 23: Key takeaways: Roche Diagnostics Exhibit 24: Key takeaways: Siemens Healthcare

Abbott Laboratories, Hologic Inc., Qiagen, Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.), Siemens Healthcare GmbH, AsuraGen, Ahram Biosystem, Analytik Jena, BD, Bio-Rad, EKF Molecular Diagnostics, EMD Millipore, HTG Molecular, InBios International, Maxim Biomedical, Mindray, Myriad Genetics, Ortho Clinical Diagnostics, Ras Lifesciences, Trivitron Healthcare, ThermoFisher Scientific.